ArticleDermatology and therapy2025
Determinants of Satisfaction with Medical Care for Hidradenitis Suppurativa: Results from a Multicentre Survey in Germany.
Article in Dermatology and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: Metainflammation and metabolism in hidradenitis suppurativa.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with considerable physical and psychosocial distress. Recent studies have reported low levels of satisfaction among patients with HS regarding the medical care of their condition. The objective of the study was to identify modifiable determinants of low satisfaction with HS care from both patient and dermatologist perspectives.
methodsThis prospective, questionnaire-based survey was conducted among patients with HS and, for comparison, among those with psoriasis, as well as their treating dermatologists, in 20 dermatological centres in Germany.
resultsA total of 257 patients and 76 dermatologists participated in the study. The proportion of patients reporting high satisfaction with care for their skin disease (scores > 8 on a 0-10 scale) was 30.7% for HS and 69.4% for psoriasis (P < 0.001). The proportion of dermatologists highly satisfied with medical care for HS and psoriasis was 0.0% and 38.9%, respectively (P < 0.001). Multiple regression modelling revealed that satisfaction with pharmacotherapy was the primary predictor of medical care satisfaction for both patients and dermatologists. Experience with systemic antibiotics was associated with lower patient satisfaction regarding pharmacotherapy, while satisfaction tended to be higher when patients had experienced therapy with biologics. Another significant determinant of patient satisfaction with medical care was the provision of information about HS by dermatologists, which was linked to consultations occurring at least quarterly and lasting ≥ 20 min. No association was observed between disease severity and the identified determinants of patient satisfaction with medical care. Dermatologists' satisfaction with medical care was additionally linked with the perceived availability of referral options to other dermatological facilities.
conclusionsImprovements in patient satisfaction with HS care may be achieved through enhanced patient education about the disease and regular dermatologist consultations; however, optimal HS management ultimately requires effective pharmacological treatment.
trial registrationdrks.de, DRKS00031572.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.